“[The] patient seems to have made a full recovery with no ill effects that we are aware of and is able to control the mouse, move the mouse around the screen just by thinking,” Mr. Musk said during a live audio Spaces session on social media platform X.
Neuralink, Mr. Musk’s neurotechnology company, implanted the chip into the first patient in January. Neuralink did not respond to CNBC’s request for comment.
The company was founded in 2017 and aims to use a chip implanted in the brain to help humans use their neural signals to control external technologies.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
